Csergeova L, Krbusek D, Janostiak R
Cell Div. 2024; 19(1):11.
PMID: 38561743
PMC: 10985988.
DOI: 10.1186/s13008-024-00115-z.
de la Camara C, Storm T, Salman A, Burgoyne T, Rasmussen M, Orlans H
J Histochem Cytochem. 2023; 71(6):301-320.
PMID: 37350564
PMC: 10315990.
DOI: 10.1369/00221554231184286.
Palmer A, Epton S, Crawley E, Straface M, Gammon L, Edgar M
Front Neurosci. 2021; 15:747067.
PMID: 34690683
PMC: 8529329.
DOI: 10.3389/fnins.2021.747067.
Jovanovic D, Mitrovic S, Milosavljevic M, Ilic M, Stankovic V, Vuletic M
Healthcare (Basel). 2021; 9(9).
PMID: 34575014
PMC: 8468846.
DOI: 10.3390/healthcare9091240.
Mendaza S, Fernandez-Irigoyen J, Santamaria E, Zudaire T, Guarch R, Guerrero-Setas D
Int J Mol Sci. 2020; 21(6).
PMID: 32204550
PMC: 7139571.
DOI: 10.3390/ijms21062125.
CSN6 promotes tumorigenesis of gastric cancer by ubiquitin-independent proteasomal degradation of p16.
Du W, Liu Z, Zhu W, Li T, Zhu Z, Wei L
Cancer Biol Med. 2019; 16(3):514-529.
PMID: 31565481
PMC: 6743625.
DOI: 10.20892/j.issn.2095-3941.2018.0410.
Comparing progression molecular mechanisms between lung adenocarcinoma and lung squamous cell carcinoma based on genetic and epigenetic networks: big data mining and genome-wide systems identification.
Yeh S, Chang C, Li C, Wang L, Chen B
Oncotarget. 2019; 10(38):3760-3806.
PMID: 31217907
PMC: 6557199.
DOI: 10.18632/oncotarget.26940.
Evaluation of 14-3-3 sigma as a potential partner of p16 in quiescence and differentiation.
Agarwal P, DeInnocentes P, Bird R
In Vitro Cell Dev Biol Anim. 2018; 54(9):658-665.
PMID: 30168069
DOI: 10.1007/s11626-018-0291-1.
The Contrasting Role of p16Ink4A Patterns of Expression in Neuroendocrine and Non-Neuroendocrine Lung Tumors: A Comprehensive Analysis with Clinicopathologic and Molecular Correlations.
Fusco N, Guerini-Rocco E, Del Gobbo A, Franco R, Zito-Marino F, Vaira V
PLoS One. 2015; 10(12):e0144923.
PMID: 26674347
PMC: 4684221.
DOI: 10.1371/journal.pone.0144923.
p16(INK4a) expression in retinoblastoma: a marker of differentiation grade.
Liu Y, Zhong X, Wan S, Zhang W, Lin J, Zhang P
Diagn Pathol. 2014; 9:180.
PMID: 25499675
PMC: 4300043.
DOI: 10.1186/s13000-014-0180-1.
Expression levels of autophagy related proteins and their prognostic significance in retinocytoma and retinoblastoma.
Liu Y, Wan S, Zhang P, Zhang W, Zheng J, Lin J
Int J Ophthalmol. 2014; 7(4):594-601.
PMID: 25161927
PMC: 4137191.
DOI: 10.3980/j.issn.2222-3959.2014.04.02.
The cyclin-dependent kinase inhibitor p16INK4a physically interacts with transcription factor Sp1 and cyclin-dependent kinase 4 to transactivate microRNA-141 and microRNA-146b-5p spontaneously and in response to ultraviolet light-induced DNA damage.
Al-Khalaf H, Mohideen P, Nallar S, Kalvakolanu D, Aboussekhra A
J Biol Chem. 2013; 288(49):35511-25.
PMID: 24163379
PMC: 3853297.
DOI: 10.1074/jbc.M113.512640.
p16 Stimulates CDC42-dependent migration of hepatocellular carcinoma cells.
Chen Y, Chu H, Lin Z, Shiah W, Chou C, Klimstra D
PLoS One. 2013; 8(7):e69389.
PMID: 23894465
PMC: 3722281.
DOI: 10.1371/journal.pone.0069389.
p16INK4A represses breast stromal fibroblasts migration/invasion and their VEGF-A-dependent promotion of angiogenesis through Akt inhibition.
Al-Ansari M, Hendrayani S, Tulbah A, Al-Tweigeri T, Shehata A, Aboussekhra A
Neoplasia. 2013; 14(12):1269-77.
PMID: 23308058
PMC: 3540951.
DOI: 10.1593/neo.121632.
p16(INK4A) represses the paracrine tumor-promoting effects of breast stromal fibroblasts.
Al-Ansari M, Hendrayani S, Shehata A, Aboussekhra A
Oncogene. 2012; 32(18):2356-64.
PMID: 22751126
PMC: 3679618.
DOI: 10.1038/onc.2012.270.
Identification of nitration sites by peroxynitrite on p16 protein.
Luo Y, Li J, Zhang N, Wang Y, Zhong R
Protein J. 2012; 31(5):393-400.
PMID: 22576576
DOI: 10.1007/s10930-012-9414-9.
Optimization of immunolocalization of cell cycle proteins in human corneal endothelial cells.
He Z, Campolmi N, Ha Thi B, Dumollard J, Peoch M, Garraud O
Mol Vis. 2012; 17:3494-511.
PMID: 22219645
PMC: 3249439.
Data integration workflow for search of disease driving genes and genetic variants.
Karinen S, Heikkinen T, Nevanlinna H, Hautaniemi S
PLoS One. 2011; 6(4):e18636.
PMID: 21533266
PMC: 3075259.
DOI: 10.1371/journal.pone.0018636.
Malignant transformation in a defined genetic background: proteome changes displayed by 2D-PAGE.
Putz S, Vogiatzi F, Stiewe T, Sickmann A
Mol Cancer. 2010; 9:254.
PMID: 20860785
PMC: 2955615.
DOI: 10.1186/1476-4598-9-254.
Proteome-wide identification of novel binding partners to the oncogenic fusion gene protein, NPM-ALK, using tandem affinity purification and mass spectrometry.
Wu F, Wang P, Young L, Lai R, Li L
Am J Pathol. 2009; 174(2):361-70.
PMID: 19131589
PMC: 2630546.
DOI: 10.2353/ajpath.2009.080521.